Sung-Ju Moon

615 total citations
6 papers, 209 citations indexed

About

Sung-Ju Moon is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Sung-Ju Moon has authored 6 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Sung-Ju Moon's work include Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (3 papers) and Chemical Synthesis and Analysis (2 papers). Sung-Ju Moon is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (3 papers) and Chemical Synthesis and Analysis (2 papers). Sung-Ju Moon collaborates with scholars based in United States. Sung-Ju Moon's co-authors include Thomas M. Cardillo, David M. Goldenberg, Serengulam V. Govindan, Hans J. Hansen, Christopher D'Souza, Fatma Tat, Roberto Arrojo, David Goldenberg, Ingrid B.J. Joseph and David R. Stover and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Sung-Ju Moon

6 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sung-Ju Moon United States	3	153	119	77	21	20	6	209
Nick Knudsen United States	7	194 1.3×	169 1.4×	94 1.2×	35 1.7×	31 1.6×	12	286
Kirsten Achilles Poon United States	6	180 1.2×	142 1.2×	74 1.0×	23 1.1×	14 0.7×	6	278
Aimee Fourie-O’Donohue France	9	180 1.2×	187 1.6×	103 1.3×	26 1.2×	31 1.6×	10	279
Yoshinobu Shiose Japan	8	85 0.6×	43 0.4×	111 1.4×	30 1.4×	24 1.2×	14	208
Shaoyi Li United States	4	123 0.8×	61 0.5×	117 1.5×	14 0.7×	6 0.3×	5	227
Elena Ter‐Ovanesyan	6	117 0.8×	105 0.9×	49 0.6×	16 0.8×	13 0.7×	11	163
Lillian Skidmore Italy	5	157 1.0×	133 1.1×	47 0.6×	39 1.9×	9 0.5×	11	192
Suzanna Clark United States	5	94 0.6×	89 0.7×	103 1.3×	10 0.5×	7 0.3×	5	199
Elisabetta Landucci Italy	9	137 0.9×	68 0.6×	50 0.6×	41 2.0×	4 0.2×	17	261
A. Passioukov Switzerland	7	90 0.6×	36 0.3×	57 0.7×	80 3.8×	18 0.9×	15	198

Countries citing papers authored by Sung-Ju Moon

Since Specialization

Citations

This map shows the geographic impact of Sung-Ju Moon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung-Ju Moon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung-Ju Moon more than expected).

Fields of papers citing papers by Sung-Ju Moon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung-Ju Moon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung-Ju Moon. The network helps show where Sung-Ju Moon may publish in the future.

Co-authorship network of co-authors of Sung-Ju Moon

This figure shows the co-authorship network connecting the top 25 collaborators of Sung-Ju Moon. A scholar is included among the top collaborators of Sung-Ju Moon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung-Ju Moon. Sung-Ju Moon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Rudra-Ganguly, Nandini, Claudia Guevara, Christopher C. Kemball, et al.. (2014). Abstract 1976: MDR expression/ activity may serve as potential biomarker in developing therapeutic drugs for AML therapy. Cancer Research. 74(19_Supplement). 1976–1976. 1 indexed citations

2.

Govindan, Serengulam V., Thomas M. Cardillo, Sung-Ju Moon, et al.. (2010). Abstract 2438: Efficacious therapies of two human pancreatic cancer xenografts and an aggressive human lymphoma xenograft with redesigned antibody-SN-38 conjugates. Cancer Research. 70(8_Supplement). 2438–2438. 1 indexed citations

3.

Moon, Sung-Ju, Fatma Tat, Roberto Arrojo, et al.. (2010). Abstract 2439: Cross-linker evaluation in the design of antibody-SN-38 conjugates for cancer therapy. Cancer Research. 70(8_Supplement). 2439–2439. 4 indexed citations

4.

Govindan, Serengulam V., Thomas M. Cardillo, Sung-Ju Moon, & David Goldenberg. (2009). Abstract #3233: Targeted therapy of human colonic, lung, and pancreatic cancer xenografts, growing in nude mice, with potent antibody conjugates of SN-38. Cancer Research. 69. 3233–3233. 1 indexed citations

5.

Govindan, Serengulam V., Thomas M. Cardillo, Sung-Ju Moon, Hans J. Hansen, & David M. Goldenberg. (2009). CEACAM5-Targeted Therapy of Human Colonic and Pancreatic Cancer Xenografts with Potent Labetuzumab-SN-38 Immunoconjugates. Clinical Cancer Research. 15(19). 6052–6061. 80 indexed citations

6.

Moon, Sung-Ju, Serengulam V. Govindan, Thomas M. Cardillo, et al.. (2008). Antibody Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN-38) for Targeted Cancer Chemotherapy. Journal of Medicinal Chemistry. 51(21). 6916–6926. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact